Free Trial

$3.5B GlaxoSmithKline launched Date $MM....>

PIPELINE
PIPELINE: $3.5B GlaxoSmithKline launched
Date $MM Issuer/Rating/Desc/Maturity/Yld/Leads; Priced *; Launch #:
03/18 $3.5B #GlaxoSmithKline Capital $1.5B 3Y fix +50, $1B 5Y +70, $1B 10Y +90
03/18 $1B #Target 10Y +78
03/18 $1.5B #BNP Paribas PerpNC5 6.625%
03/18 $750M #SEB (Skandinaviska Enskilda Banken) 3Y +68
03/18 $400M #Kansas City Power $ Light WNG 30Y +115
03/18 $2.75B ADT 5NCL, 7NCL, 8NCL
03/18 $800M Louisville Gas/Kentucky Utilities WNG 26Y, 30Y

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.